Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds

被引：25

作者：

Dhar, T. G. Murali ^{[1
]}

Wrobleski, Stephen T. ^{[1
]}

Lin, Shuqun ^{[1
]}

Furch, Joseph A. ^{[1
]}

Nirschl, David S. ^{[1
]}

Fan, Yi ^{[1
]}

Todderud, Gordon ^{[1
]}

Pitt, Sidney ^{[1
]}

Doweyko, Arthur M. ^{[1
]}

Sack, John S. ^{[1
]}

Mathur, Arvind ^{[1
]}

McKinnon, Murray ^{[1
]}

Barrish, Joel C. ^{[1
]}

Dodd, John H. ^{[1
]}

Schieven, Gary L. ^{[1
]}

Leftheris, Katerina ^{[1
]}

机构：

[1] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 18期

关键词：

p38; alpha; MAP kinase inhibitors; TNF alpha; X-ray co-crystallography;

D O I：

10.1016/j.bmcl.2007.07.029

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis and structure-activity relationships (SAR) of p38 alpha MAP kinase inhibitors based on heterobicyclic scaffolds are described. This effort led to the identification of compound (21) as a potent inhibitor of p38a MAP kinase with good cellular potency toward the inhibition of TNF-alpha production. X-ray co-crystallography of an oxalamide analog (24) bound to unphosphorylated p38 alpha is also disclosed. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：5019 / 5024

页数：6

共 50 条

[31] Substituted isoxazoles as potent inhibitors of p38 MAP kinase
Laufer, Stefan A.
Margutti, Simona
Fritz, Martina D.
CHEMMEDCHEM, 2006, 1 (02) : 197 - 207
[32] Synthesis of a naphthyridone p38 MAP kinase inhibitor
Chung, John Y. L.
Cvetovich, Raymond J.
McLaughlin, Mark
Amato, Joseph
Tsay, Fuh-Rong
Jensen, Mark
Weissman, Steve
Zewge, Daniel
JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (22): : 8602 - 8609
[33] Practical Synthesis of a p38 MAP Kinase Inhibitor
Achmatowicz, Michal
Thiel, Oliver R.
Wheeler, Philip
Bernard, Charles
Huang, Jinkun
Larsen, Robert D.
Faul, Margaret M.
JOURNAL OF ORGANIC CHEMISTRY, 2009, 74 (02): : 795 - 809
[34] Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase
Stelmach, JE
Liu, LP
Patela, SB
Pivnichny, JV
Scapin, G
Singh, S
Hop, CECA
Wang, Z
Strauss, JR
Cameron, PM
Nichols, EA
O'Keefe, SJ
O'Neill, EA
Schmatz, DM
Schwartz, CD
Thompson, CM
Zaller, DM
Doherty, JB
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (02) : 277 - 280
[35] SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors
Revesz, L
Di Padova, FE
Buhl, T
Feifel, R
Gram, H
Hiestand, P
Manning, U
Zimmerlin, AG
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (11) : 1261 - 1264
[36] MAP kinase p38 inhibitors:: Clinical results and an intimate look at their interactions with p38α protein
Lee, MR
Dominguez, C
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (25) : 2979 - 2994
[37] P38 kinase inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 2000, 5 (12) : 570 - 571
[38] Inhibitors of p38 kinase
Hanson, GJ
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (07) : 729 - 733
[39] Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR
Angell, Richard M.
Angell, Tony D.
Bamborough, Paul
Brown, David
Brown, Murray
Buckton, Jacky B.
Cockerill, Stuart G.
Edwards, Chris D.
Jones, Katherine L.
Longstaff, Tim
Smee, Penny A.
Smith, Kathryn J.
Somers, Don O.
Walker, Ann L.
Willson, Malcolm
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 324 - 328
[40] Isoxazolone based inhibitors of p38 MAP kinases
Laufer, Stefan A.
Margutti, Simona
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (08) : 2580 - 2584

← 1 2 3 4 5 →